• Investing in Pharma (Part 1) - Divi's Laboratories

  • Jan 8 2024
  • Duración: 11 m
  • Podcast

Investing in Pharma (Part 1) - Divi's Laboratories

  • Resumen

  • Investing in Pharma (Part 1) - Divi's Laboratories

    Being one of the biggest API manufacturers in the world, Divi's stock prices are quite expensive. In this episode, I breakdown the reasons as to why the company is trading at a PE of 71 while also giving an account of the risks the company faces and; eventually, attempting to decide if the stock prices are justified. Tune in to find out more about Divi's Labs.

    Read the full blog here

    Más Menos

Lo que los oyentes dicen sobre Investing in Pharma (Part 1) - Divi's Laboratories

Calificaciones medias de los clientes

Reseñas - Selecciona las pestañas a continuación para cambiar el origen de las reseñas.